HealthExec February 21, 2024
The lead story in Tuesday’s Politico Pulse newsletter will feel familiar to anybody struggling to keep up with the ever-changing AI landscape.
Unfortunately, the subject of this story is the FDA, whose lack of resources to keep up with AI advancement is hindering the agency’s ability to serve its role as regulator.
“Rather than issuing a one-time approval, FDA wants to monitor artificial intelligence products over time, something it’s never done proactively,” writes health-tech reporter Ruth Reader.
Moreover,...
Today's Sponsors
Today's Sponsor